Healthcare & Medical Devices Global On demand · 24-48h

Global Specimen Collection Device Market Strategic Research Report

Global Specimen Collection Device Market Strategic Research …
$3,500 USD
Market Research Reports
Strategic Research Report
Global Specimen Collection Device Market
$6852025
10.3%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Non-Sterile, Sterile

By Application: Healthcare, Life Sciences, Public Health, Food & Environmental Testing, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: BD, Thermo Fisher Scientific, Medtronic, Terumo, Nipro, Cook Medical, WEGO, Greiner Bio-One, Sarstedt, Sekisui Medical, Copan, Improve Medical, Gongdong Medical, Xinle Medical, OraSure Technologies, Puritan Medical Products, Ambu, DeRoyal, Kangjian Medical, FL Medical, Deltalab, Hardy Diagnostics, Foamtec International, Texwipe, Arlington Scientific, VTP Medical, Kangshi Medical, Shanghai Orsin Medical

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 174 pages
Market size 2025
$685
Million USD
Forecast CAGR
10.3%
2025-2032
Forecast 2032
$1360.6
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

نظرة عامة

Scope of the Report

The global Specimen Collection Device market size is predicted to grow from US$ 685 million in 2025 to US$ 1,352 million in 2032; it is expected to grow at a CAGR of 10.3% from 2026 to 2032.

Specimen Collection Device refers to a dedicated medical or testing device or consumable used to obtain, temporarily store, protect, and transport specimens from the human body, animals, the environment, or object surfaces. Its product forms commonly include blood collection tubes, blood collection needles, specimen cups, urine containers, saliva collectors, nasopharyngeal swabs, throat swabs, stool collectors, tissue specimen bags, transport tubes, preservation-medium tubes, and combined collection kits. A typical device consists of a sampling end, containment chamber, sealing cap, labeling area, additive or preservation medium, and protective packaging; some products also include a vacuum system, anti-backflow structure, break-point swab shaft, transport medium, anticoagulant, stabilizer, or inactivation preservation solution. Its working principle is to obtain the target specimen through physical contact, negative-pressure aspiration, capillary action, container collection, or tissue retrieval, and to reduce contamination, leakage, degradation, coagulation, microbial death, or nucleic acid instability through sterile barriers, sealing structures, material compatibility, additive formulations, and temperature-controlled transport conditions. By product category, it can be divided into collection tubes, containers, swabs, blood collection sets, transport systems, tissue specimen retrieval devices, and collection kits. It is mainly used in healthcare, life sciences, public health, food and environmental testing, and other testing scenarios.

The market development opportunities for Specimen Collection Devices mainly arise from the earlier positioning of diagnostics, the expansion of testing scenarios, and higher standards for specimen management. Healthcare institutions, independent clinical laboratories, public health systems, and research organizations are placing greater emphasis on high-quality sampling, stable preservation, and safe transportation, driving upgrades in blood collection tubes, swabs, specimen cups, preservation tubes, and integrated collection kits. The growth of molecular diagnostics, respiratory pathogen testing, genetic testing, home-based sampling, and clinical trial specimen management is also increasing demand for sterile, standardized, disposable, traceable, and automation-compatible products. As test accuracy becomes more dependent on pre-analytical quality, specimen collection devices are evolving from low-value consumables into essential products that influence diagnostic reliability, laboratory efficiency, and infection control.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Specimen Collection Device market?

What factors are driving Specimen Collection Device market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Specimen Collection Device market opportunities vary by end market size?

How does Specimen Collection Device break out by Type, by Application?

This report presents a comprehensive overview of the global Specimen Collection Device market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Non-Sterile
  • Sterile

Segment by Material

  • Plastic-Based Devices
  • Glass-Based Devices
  • Metal-Component Devices
  • Fiber-Based Devices
  • Foam-Based Devices
  • Composite-Material Devices
  • Others

Segment by Specimen Type

  • Blood Collection Devices
  • Urine Collection Devices
  • Saliva and Oral Fluid Collection Devices
  • Respiratory Specimen Collection Devices
  • Stool Collection Devices
  • Tissue and Cell Collection Devices
  • Surface and Environmental Sampling Devices
  • Others

Segment by Application

  • Healthcare
  • Life Sciences
  • Public Health
  • Food & Environmental Testing
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Specimen Collection Device market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Healthcare, Life Sciences, Public Health evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Specimen Collection Device Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 10.3%
Regional growth momentum
Market share by segment
Key metrics
Base value
$685
2025
Forecast
$1360.6
2032
CAGR
10.3%
2025–2032
Regions
5
global
Key companies
BDThermo Fisher ScientificMedtronicTerumoNiproCook MedicalWEGOGreiner Bio-One
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Non-SterileSterile
By Application
HealthcareLife SciencesPublic HealthFood & Environmental TestingOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Non-Sterile
  • 3.1.3 Sterile
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Healthcare
  • 4.1.3 Life Sciences
  • 4.1.4 Public Health
  • 4.1.5 Food & Environmental Testing
  • 4.1.6 Others
  • 4.1.7 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 BD
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Thermo Fisher Scientific
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Medtronic
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Terumo
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Nipro
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Cook Medical
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 WEGO
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Greiner Bio-One
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Sarstedt
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Sekisui Medical
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Copan
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Improve Medical
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Gongdong Medical
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Xinle Medical
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 OraSure Technologies
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Puritan Medical Products
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Ambu
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 DeRoyal
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Kangjian Medical
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 FL Medical
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 Deltalab
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
  • 8.22 Hardy Diagnostics
  • 8.22.1 Company Overview
  • 8.22.2 Key Products & Segments
  • 8.22.3 Financial Performance (2023–2025)
  • 8.22.4 Business Strategy
  • 8.22.5 SWOT Analysis
  • 8.22.6 Strategic Implications (2026–2032)
  • 8.23 Foamtec International
  • 8.23.1 Company Overview
  • 8.23.2 Key Products & Segments
  • 8.23.3 Financial Performance (2023–2025)
  • 8.23.4 Business Strategy
  • 8.23.5 SWOT Analysis
  • 8.23.6 Strategic Implications (2026–2032)
  • 8.24 Texwipe
  • 8.24.1 Company Overview
  • 8.24.2 Key Products & Segments
  • 8.24.3 Financial Performance (2023–2025)
  • 8.24.4 Business Strategy
  • 8.24.5 SWOT Analysis
  • 8.24.6 Strategic Implications (2026–2032)
  • 8.25 Arlington Scientific
  • 8.25.1 Company Overview
  • 8.25.2 Key Products & Segments
  • 8.25.3 Financial Performance (2023–2025)
  • 8.25.4 Business Strategy
  • 8.25.5 SWOT Analysis
  • 8.25.6 Strategic Implications (2026–2032)
  • 8.26 VTP Medical
  • 8.26.1 Company Overview
  • 8.26.2 Key Products & Segments
  • 8.26.3 Financial Performance (2023–2025)
  • 8.26.4 Business Strategy
  • 8.26.5 SWOT Analysis
  • 8.26.6 Strategic Implications (2026–2032)
  • 8.27 Kangshi Medical
  • 8.27.1 Company Overview
  • 8.27.2 Key Products & Segments
  • 8.27.3 Financial Performance (2023–2025)
  • 8.27.4 Business Strategy
  • 8.27.5 SWOT Analysis
  • 8.27.6 Strategic Implications (2026–2032)
  • 8.28 Shanghai Orsin Medical
  • 8.28.1 Company Overview
  • 8.28.2 Key Products & Segments
  • 8.28.3 Financial Performance (2023–2025)
  • 8.28.4 Business Strategy
  • 8.28.5 SWOT Analysis
  • 8.28.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Specimen Collection Device market size?
The global Specimen Collection Device market is estimated at US$ 685 million in 2025 (base year) and is projected to reach US$ 1.35 billion by 2032.
What growth rate is expected for the Specimen Collection Device market through 2032?
The market is expected to grow at a CAGR of 10.3% from 2026 to 2032, expanding from US$ 685 million in 2025 to US$ 1.35 billion in 2032, roughly 2.0 times its base-year value.
How is Specimen Collection Device defined?
Specimen Collection Device refers to a dedicated medical or testing device or consumable used to obtain, temporarily store, protect, and transport specimens from the human body, animals, the environment, or object surfaces. Its product forms commonly include blood collection tubes, blood collection needles, specimen cups, urine containers, saliva collectors, nasopharyngeal swabs, throat swabs, stool collectors, tissue specimen bags, transport tubes, preservation-medium tubes, and combined collection kits.
How is the Specimen Collection Device market segmented by type?
By type, the market is segmented into Non-Sterile and Sterile.
What are the key applications of Specimen Collection Device?
Key applications covered include Healthcare, Life Sciences, Public Health, Food & Environmental Testing and Others.
Which companies are profiled in the Specimen Collection Device market report?
Key players profiled include BD, Thermo Fisher Scientific, Medtronic, Terumo, Nipro, Cook Medical, WEGO and Greiner Bio-One, among 28 companies covered in total.
What geographies does the Specimen Collection Device market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Specimen Collection Device?
Healthcare institutions, independent clinical laboratories, public health systems, and research organizations are placing greater emphasis on high-quality sampling, stable preservation, and safe transportation, driving upgrades in blood collection tubes, swabs, specimen cups, preservation tubes, and integrated collection kits.
Who should buy the Specimen Collection Device market report?
The report is intended for manufacturers and solution providers, distributors and end users in Healthcare, Life Sciences and Public Health, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Specimen Collection Device market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from ‏3,500.00 US$
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.